» Articles » PMID: 29695020

Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and Following Immune Thrombocytopenia

Abstract

Neonatal platelets are hypo-reactive to the tyrosine kinase-linked receptor agonist collagen. Here, we have investigated whether the hypo-responsiveness is related to altered levels of glycoprotein VI (GPVI) and integrin α2β1, or to defects in downstream signalling events by comparison to platelet activation by C-type lectin-like receptor 2 (CLEC-2). GPVI and CLEC-2 activate a Src- and Syk-dependent signalling pathway upstream of phospholipase C (PLC) γ2. Phosphorylation of a conserved YxxL sequence known as a (hemi) immunotyrosine-based-activation-motif (ITAM) in both receptors is critical for Syk activation. Platelets from human pre-term and full-term neonates display mildly reduced expression of GPVI and CLEC-2, as well as integrin αIIbβ3, accounted for at the transcriptional level. They are also hypo-responsive to the two ITAM receptors, as shown by measurement of integrin αIIbβ3 activation, P-selectin expression and Syk and PLCγ2 phosphorylation. Mouse platelets are also hypo-responsive to GPVI and CLEC-2 from late gestation to 2 weeks of age, as determined by measurement of integrin αIIbβ3 activation. In contrast, the response to G protein-coupled receptor agonists was only mildly reduced and in some cases not altered in neonatal platelets of both species. A reduction in response to GPVI and CLEC-2, but not protease-activated receptor 4 (PAR-4) peptide, was also observed in adult mouse platelets following immune thrombocytopenia, whereas receptor expression was not impaired. Our results demonstrate developmental differences in platelet responsiveness to GPVI and CLEC-2, and also following immune platelet depletion leading to reduced Syk activation. The rapid generation of platelets during development or following platelet depletion is achieved at the expense of signalling by ITAM-coupled receptors.

Citing Articles

Demographic diversity in platelet function and response to antiplatelet therapy.

Jain K, Tyagi T, Gu S, Faustino E, Hwa J Trends Pharmacol Sci. 2024; 46(1):78-93.

PMID: 39672782 PMC: 11710996. DOI: 10.1016/j.tips.2024.11.005.


Quantitative label-free mass spectrometry reveals content and signaling differences between neonatal and adult platelets.

Thom C, Davenport P, Fazelinia H, Soule-Albridge E, Liu Z, Zhang H J Thromb Haemost. 2023; 22(5):1447-1462.

PMID: 38160730 PMC: 11055671. DOI: 10.1016/j.jtha.2023.12.022.


Composition of thrombi in zebrafish: similarities and distinctions with mammals.

Griffin M, Dahlgren A, Nagaswami C, Litvinov R, Keeler K, Madenjian C J Thromb Haemost. 2023; 22(4):1056-1068.

PMID: 38160724 PMC: 11293624. DOI: 10.1016/j.jtha.2023.12.025.


The Hemostatic System in Newborns and the Risk of Neonatal Thrombosis.

Khizroeva J, Makatsariya A, Vorobev A, Bitsadze V, Elalamy I, Lazarchuk A Int J Mol Sci. 2023; 24(18).

PMID: 37762167 PMC: 10530883. DOI: 10.3390/ijms241813864.


Ontogenesis of functional platelet subpopulations from preterm and term neonates to adulthood: The PLINIUS study.

Weiss L, Drayss M, Mott K, Beck S, Unsin D, Just B Blood Adv. 2023; 7(16):4334-4348.

PMID: 37042931 PMC: 10432615. DOI: 10.1182/bloodadvances.2023009824.


References
1.
Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W . Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets. 2010; 21(8):641-7. DOI: 10.3109/09537104.2010.504869. View

2.
Hezard N, Potron G, Schlegel N, Amory C, Leroux B, Nguyen P . Unexpected persistence of platelet hyporeactivity beyond the neonatal period: a flow cytometric study in neonates, infants and older children. Thromb Haemost. 2003; 90(1):116-23. View

3.
Weinberg R, Schofield J, Lenes A, Brochstein J, Alter B . Adult 'fetal-like' erythropoiesis characterizes recovery from bone marrow transplantation. Br J Haematol. 1986; 63(3):415-24. DOI: 10.1111/j.1365-2141.1986.tb07518.x. View

4.
Carsetti L, Laurenti L, Gobessi S, Longo P, Leone G, Efremov D . Phosphorylation of the activation loop tyrosines is required for sustained Syk signaling and growth factor-independent B-cell proliferation. Cell Signal. 2009; 21(7):1187-94. DOI: 10.1016/j.cellsig.2009.03.007. View

5.
Tesfamariam B . Distinct characteristics of neonatal platelet reactivity. Pharmacol Res. 2017; 123:1-9. DOI: 10.1016/j.phrs.2017.06.003. View